Residual bile flow shapes PPARγ-mediated antifibrotic responses in experimental segmental cholestasis

Segmental cholestasis represents a clinically relevant but underexplored cause of progressive liver fibrosis, particularly in pediatric conditions associated with intrahepatic biliary strictures, where segmental obstruction promotes progressive fibro-inflammatory injury that extends into adjacent non-cholestatic parenchyma. The mechanisms determining regional therapeutic responsiveness in segmental cholestasis remain poorly defined. . Here, we investigated the effects of PPARγ agonism in a selective bile duct ligation (sBDL) model that reproduces key features of segmental cholestasis and the propagation of fibro-inflammatory signaling beyond the primary site of injury. Newly weaned Wistar rats underwent sBDL and were treated with the PPARγ agonist pioglitazone or vehicle. Cholestatic (CL) and non-cholestatic (NCL) liver lobes were analyzed at 7, 30, and 60 days post-surgery using histological, immunohistochemical, biochemical, transcriptomic, and gene co-expression network analyses. Therapeutic responsiveness was strongly region dependent. In non-cholestatic lobe (NCL-T), PPARγ activation reduced macrophage recruitment, ductular reaction, and collagen deposition, accompanied by downregulated inflammatory and TGF-β–related signaling pathways. Gene co-expression network analysis revealed that PPARγ activation showed a hierarchical gene network topology and functional modularity in treated non-cholestatic lobes, preventing the network collapse observed in vehicle-treated animals. In contrast, the cholestatic lobe (CL-T) showed limited transcriptional responsiveness and remained largely refractory to therapeutic modulation, consistent with a stabilized fibro-inflammatory microenvironment. These findings demonstrate that injury heterogeneity and partial preservation of bile flow critically determine of therapeutic responsiveness, supporting PPARγ activation as a preventive antifibrotic strategy to limit fibro-inflammatory propagation in vulnerable hepatic regions during segmental cholestasis.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-04-25
DOI
https://doi.org/10.1038/s41598-026-50023-1
Primary Topic
Liver physiology and pathology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Residual bile flow shapes PPARγ-mediated antifibrotic responses in experimental segmental cholestasis

Bruno Cogliati, Uenis Tannuri, Isac de Castro, Suellen Serafini et al.
Scientific Reports
Liver physiology and pathology
article

Residual bile flow shapes PPARγ-mediated antifibrotic responses in experimental segmental cholestasis

Bruno Cogliati, Uenis Tannuri, Isac de Castro, Suellen Serafini, Cleiton A M Mafra, L F Ferreira, Silvia Y. Bando, Walcy R. Teodoro, Josiane O. Gonçalves, Ana C. A. Tannuri, Carlos A. Moreira-Filho
article en

Abstract

Segmental cholestasis represents a clinically relevant but underexplored cause of progressive liver fibrosis, particularly in pediatric conditions associated with intrahepatic biliary strictures, where segmental obstruction promotes progressive fibro-inflammatory injury that extends into adjacent non-cholestatic parenchyma. The mechanisms determining regional therapeutic responsiveness in segmental cholestasis remain poorly defined. . Here, we investigated the effects of PPARγ agonism in a selective bile duct ligation (sBDL) model that reproduces key features of segmental cholestasis and the propagation of fibro-inflammatory signaling beyond the primary site of injury. Newly weaned Wistar rats underwent sBDL and were treated with the PPARγ agonist pioglitazone or vehicle. Cholestatic (CL) and non-cholestatic (NCL) liver lobes were analyzed at 7, 30, and 60 days post-surgery using histological, immunohistochemical, biochemical, transcriptomic, and gene co-expression network analyses. Therapeutic responsiveness was strongly region dependent. In non-cholestatic lobe (NCL-T), PPARγ activation reduced macrophage recruitment, ductular reaction, and collagen deposition, accompanied by downregulated inflammatory and TGF-β–related signaling pathways. Gene co-expression network analysis revealed that PPARγ activation showed a hierarchical gene network topology and functional modularity in treated non-cholestatic lobes, preventing the network collapse observed in vehicle-treated animals. In contrast, the cholestatic lobe (CL-T) showed limited transcriptional responsiveness and remained largely refractory to therapeutic modulation, consistent with a stabilized fibro-inflammatory microenvironment. These findings demonstrate that injury heterogeneity and partial preservation of bile flow critically determine of therapeutic responsiveness, supporting PPARγ activation as a preventive antifibrotic strategy to limit fibro-inflammatory propagation in vulnerable hepatic regions during segmental cholestasis.

Scientific Reports
Universidade de São Paulo (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Universidade Federal de São Paulo (BR)
Fundação de Amparo à Pesquisa do Estado de São Paulo
Openalex Percentile: Top 21%
Liver physiology and pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.